Merrimack Pharmaceuticals Stock Forecast - Daily Balance Of Power
MACKDelisted Stock | USD 11.96 0.12 1.01% |
Merrimack Stock Forecast is based on your current time horizon.
Merrimack |
Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
0.4545 | 0.7059 |
Check Merrimack Pharmaceuticals Volatility | Backtest Merrimack Pharmaceuticals | Trend Details |
Merrimack Pharmaceuticals Trading Date Momentum
On November 27 2024 Merrimack Pharmaceuticals was traded for 11.96 at the closing time. The top price for the day was 12.01 and the lowest listed price was 11.84 . There was no trading activity during the period 0.0. Lack of trading volume on November 27, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.00% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Merrimack Pharmaceuticals to competition
Merrimack Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Merrimack Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Merrimack Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Merrimack Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Merrimack Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Merrimack Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Merrimack Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Merrimack Pharmaceuticals stock market strength indicators, traders can identify Merrimack Pharmaceuticals entry and exit signals to maximize returns.
Merrimack Pharmaceuticals Risk Indicators
The analysis of Merrimack Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Merrimack Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting merrimack stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 0.7806 | |||
Standard Deviation | 1.12 | |||
Variance | 1.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |